72 related articles for article (PubMed ID: 29712718)
1. Persisting adverse body composition changes 2 years after cessation of androgen deprivation therapy for localised prostate cancer.
Cheung AS; Tinson AJ; Milevski SV; Hoermann R; Zajac JD; Grossmann M
Eur J Endocrinol; 2018 Jul; 179(1):21-29. PubMed ID: 29712718
[TBL] [Abstract][Full Text] [Related]
2. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
Elife; 2024 Apr; 13():. PubMed ID: 38656229
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Changes in Androgen-Deprived Nondiabetic Men With Prostate Cancer Are Not Mediated by Cytokines or aP2.
Gagliano-Jucá T; Burak MF; Pencina KM; Li Z; Edwards RR; Travison TG; Basaria S
J Clin Endocrinol Metab; 2018 Oct; 103(10):3900-3908. PubMed ID: 30032274
[TBL] [Abstract][Full Text] [Related]
4. Effects of androgen deprivation therapy on elderly men with high-risk prostate cancer: PROSARC observational study.
Legido-Gómez Ó; Rico-Marco S; Lorenzo-Sánchez MV; Navarro-Jiménez S; Tárraga-Honrubia MA; Martínez-Ruiz J; Giménez-Bachs JM; Donate-Moreno MJ; Díaz de Mera-Sánchez-Migallón I; Segura-Martín M; Alcantud-Córcoles R; Abizanda-Soler P; Salinas-Sánchez AS
Actas Urol Esp (Engl Ed); 2024 May; 48(4):304-310. PubMed ID: 38373481
[TBL] [Abstract][Full Text] [Related]
5. Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy.
Wilson RL; Newton RU; Taaffe DR; Hart NH; Lyons-Wall P; Galvão DA
Med Sci Sports Exerc; 2021 Mar; 53(3):470-478. PubMed ID: 33009195
[TBL] [Abstract][Full Text] [Related]
6. Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials.
Nabid A; Carrier N; Vigneault E; Martin AG; Bahary JP; Van Nguyen T; Vavassis P; Vass S; Brassard MA; Bahoric B; Archambault R; Vincent F; Bettahar R; Duclos M; Wilke D; Souhami L
Radiother Oncol; 2024 Jun; 195():110256. PubMed ID: 38552845
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications.
Collins L; Basaria S
Asian J Androl; 2012 Mar; 14(2):222-5. PubMed ID: 22343494
[TBL] [Abstract][Full Text] [Related]
8. Resistance Exercise Training, a Simple Intervention to Preserve Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy.
Houben LHP; Beelen M; van Loon LJC; Beijer S
Int J Sport Nutr Exerc Metab; 2024 Mar; 34(2):122-134. PubMed ID: 38048764
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study.
Dalla Volta A; Palumbo C; Zamboni S; Mazziotti G; Triggiani L; Zamparini M; Maffezzoni F; Rinaudo L; Bergamini M; Di Meo N; Caramella I; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Berruti A
J Endocrinol Invest; 2024 Feb; 47(2):335-343. PubMed ID: 37458931
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.
Alibhai SM; Timilshina N; Duff-Canning S; Breunis H; Tannock IF; Naglie G; Fleshner NE; Krahn MD; Warde P; Marzouk S; Tomlinson GA
Cancer; 2017 Jan; 123(2):237-244. PubMed ID: 27583806
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of multidisciplinary interventions in preventing metabolic syndrome and improving body composition in prostate cancer patients treated with androgen deprivation therapy: A systematic review and meta-analysis.
Yang U; Harikrishna A; Preda V; Chen J
Clin Nutr ESPEN; 2023 Dec; 58():27-49. PubMed ID: 38057016
[TBL] [Abstract][Full Text] [Related]
12. Examining the impact of androgen deprivation therapy, masculine self-esteem, and psychological flexibility on distress and quality of life in men with prostate cancer.
Chowdhury E; Horrocks T; McAteer G; Gillanders D
Psychooncology; 2024 Jan; 33(1):e6277. PubMed ID: 38282234
[TBL] [Abstract][Full Text] [Related]
13. Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study.
Sajid S; Dale W; Mustian K; Kotwal A; Heckler C; Porto M; Fung C; Mohile SG
J Geriatr Oncol; 2016 Mar; 7(2):71-80. PubMed ID: 26916611
[TBL] [Abstract][Full Text] [Related]
14. Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy.
Mafla-España MA; Torregrosa MD; Beamud-Cortés M; Bermell-Marco L; Rubio-Briones J; Cauli O
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002324
[TBL] [Abstract][Full Text] [Related]
15. HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate Cancer.
Couderc AL; Muracciole X; Nouguerede E; Rey D; Schneider S; Champsaur P; Lechevallier E; Lalys L; Villani P
J Nutr Health Aging; 2020; 24(2):205-209. PubMed ID: 32003412
[TBL] [Abstract][Full Text] [Related]
16. Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study.
Bylow K; Hemmerich J; Mohile SG; Stadler WM; Sajid S; Dale W
Urology; 2011 Apr; 77(4):934-40. PubMed ID: 21269665
[TBL] [Abstract][Full Text] [Related]
17. Myokine Expression and Tumor-Suppressive Effect of Serum after 12 wk of Exercise in Prostate Cancer Patients on ADT.
Kim JS; Wilson RL; Taaffe DR; Galvão DA; Gray E; Newton RU
Med Sci Sports Exerc; 2022 Feb; 54(2):197-205. PubMed ID: 34559721
[TBL] [Abstract][Full Text] [Related]
18. Two Elderly Men with Myasthenia Gravis during Androgen Deprivation Therapy for Prostate Cancer.
Kanazawa K; Tomizawa Y; Iseki T; Yokoyama K; Hattori N
Intern Med; 2023 Aug; 62(16):2413-2414. PubMed ID: 36631089
[TBL] [Abstract][Full Text] [Related]
19. Exergaming Improves Cardiac Risk Factors in Prostate Cancer Patients: A Single-Blinded Randomized Controlled Trial.
Villumsen BR; Frystyk J; Jørgensen MG; Hørdam B; Borre M
Games Health J; 2024 Apr; 13(2):93-99. PubMed ID: 37917926
[No Abstract] [Full Text] [Related]
20. Persistently Decreased Quality of Life and its Determinants in Previous Illicit Androgen Users.
Bulut Y; Brandt-Jacobsen N; Buhl L; Schou M; Frystyk J; Kistorp C; Rasmussen JJ
J Clin Endocrinol Metab; 2024 Jan; 109(2):e689-e697. PubMed ID: 37708363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
